CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION

Presence of myocardial infarction in patients with obesity can lead to an uncontrolled increase in proinflammatory cytokines and unfavorable course of the pathological process. Objective: to study the relationship of key inflammatory factors and the development of complications at different terms after myocardial infarction in patients with visceral obesity. The study involved 94 men with myocardial infarction. Visceral obesity was diagnosed by multi-slice computed tomography (LightspeedVCT 64 ,General Electric,USA). On the 1st and 12th day of hospitalization, we determined serum concentrations of interleukins (TNFα, IL-1β, IL-6, IL-8 IL-10 and IL-12), and C-reactive protein. Adverse cardiovascular events were documented during the next year. The most informative indicators were identified by a stepwise logistic regression analysis. In patients with myocardial infarction an imbalance of cytokine profile revealed, i.e., an increase in proinflammatory markers (TNFα, IL-1β, IL-6, IL-8, IL-12, CRP), along with decrease in IL-10, being more pronounced in cases of visceral obesity. Among the studied markers, closest relationship was observed between visceral obesity and serum concentrations of IL-6 and CRP. Over the year, adverse cardiovascular events proved to be more frequent in patients with visceral obesity. Post-infarction complication risk was associated with higher concentrations of IL-6, IL-12 and IL-10 deficiency. Hence, development of adverse cardiovascular events within a year after myocardial infarction is more typical to the patients with visceral obesity, and is accompanied by activation of proinflammatory cytokines and IL-10 deficiency.

1. Груздева О.В., Барбараш О.Л., Паличева Е.И., Дылева Ю.А., Кашталап В.В., Поликутина О.М., Акбашева О.Е. Роль свободных жирных кислот в развитии клинических осложнений атеросклероза // Атеросклероз, 2011. № 1. С. 19-25. [Gruzdeva O.V., Barbarash O.L., Palicheva E.I., Dyleva Yu.A., Kashtalap V.V., Polikutina O.M., Akbasheva O.E. The role of free fatty acids in the development of clinical complications of atherosclerosis. Ateroskleroz = Atherosclerosis , 2011, Vol. 1, pp. 19-25. [In Russ.]

2. Зыков М.В., Барбараш О.Л., Кашталап В.В., Веремеев А.В., Барбараш Л.С. Клиническая и прогностическая значимость интерлейкина-12 у пациентов с инфарктом миокарда // Медицинская иммунология, 2011. Т. 13, № 2-3. С. 219-226. [Zykov M.V., Barbarash O.L., Kashtalap V.V., Veremeev A.V., Barbarash L.S. Clinical and prognostic value of interleukin-12 in patients with acute myocardial infarction. Meditsinskaya immunologiya = Medical Immunology (Russia), 2011, Vol. 13, no. 2-3, pp. 219-226. [In Russ.]

3. Ahmad R., Al-Mass A., Atizado V., Al-Hubail A., Al-Ghimlas F., Al-Arouj M., Bennakhi A., Dermime S., Behbehani K. Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesityinduced inflammation. J. Inflamm. (Lond), 2012, Vol. 9, pp. 9-48.

4. Alexopoulos N., Katritsis D., Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis., 2014, Vol. 233, no. 1, pp. 104-112.

5. Asea A. Heat shock proteins and toll-like receptors. Handb. Exp. Pharmacol., 2008, Vol. 183, pp. 111-127.

6. Bruun J.M., Lihn A.S., Madan A.K., Pedersen S.B., Schiott K.M., Fain J.N., Richelsen B. Higher production of IL‐8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am. J. Clinical Endocrinology and Metabolism, 2004, Vol. 286, pp. E8-E13.

7. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab., 2005, Vol. 90, no. 4, pp. 2282-2289.

8. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science, 2002, Vol. 296, no. 5573, pp. 1634-1635.

9. Fain J.N., Bahouth S.W., Madan A.K. Involvement of multiple signaling pathways in the post bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem. Pharmacol., 2005, Vol. 69, no. 9, pp. 1315-1324.

10. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 2004, Vol. 145, pp. 2273-2282.

11. Frangogiannis N.G., Mendoza L.H., Lindsey M.L., Ballantyne C.M., Michael L.H., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res., 2002, Vol. 53, no. 1, pp. 31-34.

12. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annual Review of Immunology, 2011, Vol. 29, pp. 415-445.

13. Hansson G.K., Robertson A.K., Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev. Pathol., 2006, Vol. 1, pp. 297-329.

14. Kohsaka S., Menon V., Lowe A.M., Lange M., Dzavik V., Sleeper L.A., Hochman J.S. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch. Intern. Med., 2005, Vol. 165, no. 14, pp. 1643-1650.

15. Lee J. Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., Lee W.H., Fitzgerald K.A., Hwang D.H. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. Journal of Biological Chemistry, 2004, Vol. 279, no. 17, pp. 16971-16979.

16. Makki K., Froguel P. Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflammation, 2013.

17. Moschen A.R., Molnar C., Enrich B., Geiger S., Ebenbichler C.F., Tilg H. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Molecular Medicine, 2011, Vol. 17, no. 7-8, pp. 840-845.

18. Odegaard J.I., Chawla A. Pleiotropic actions of insulin resistance and inflammation inmetabolic homeostasis. Science, 2013, Vol. 339, pp. 172-177.

19. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annual Review of Physiology, 2010, Vol. 72, pp. 219-246.

20. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology, 2011, Vol. 11, no. 2, pp. 85-97.

21. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signaling. Mediators of Inflammation, 2010.

22. Satoh M., Shimoda Y., Akatsu T. Ishikawa Y., Minami Y., Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J. Heart Fail, 2006, Vol. 8, no. 8, pp. 810-815.

23. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clinical Investigation, 2006, Vol. 116, no. 7, pp. 1793-1801.

24. Takeda K., Akira S. Toll-like receptors. Curr. Protoc Immunol., 2007, Vol. 14, no. 12, pp. 112-121.

25. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest., 2003, Vol. 112, pp. 1796-1808.